CURRICULUM VITAE Luigi Cubeddu PERSONAL - College of ...

LUIGI X. CUBEDDU
64. Hoffmann, I.S. and Cubeddu, L.X. Efectos de las 2-aminotetralinas sobre la monoamino oxidasa y la liberacionde
dopamina. ASOVAC, Merida, noviembre 1980. XXX Convencion anual.
65. Cubeddu, L.X. Indicadores dela Actividad noradrenergica Central. Conferencia Magistral ASOVAC, Merida 1980.
XXX Convencion Anual.
66. Cubeddu, L.X., Barbella, Y.R., Valdivieso, L.H., Stern, A. and Marrero, A. Plasma dopamine-beta-hydroxylase in
stress and pheochromocytoma. Proc. 4th Meeting on adrenergi mechanims. Porto, sept. 29, oct. 1, 1980.
67. Cubeddu, L.X. and Hoffmann, I.S.: Effects of duration and rate of stimulation on the negative feedback regulation
of dopamine release. Soc. for Neuroscience, 1982.
68. Cubeddu, L.X., Cloutier, G., Harden, T.K., Tanner, L., Gross, K., Rogers, J.F. and Knowlton, G.: Clonidine
interaction with antidepressants: Bupropion vs. imipramine. II World Conference on Clinical Pharmacology and
Therapeutics, August 1983.
69. Cubeddu, L.X., Hoffmann, I.S. and James, M.K.: Effects of benztropine, bupropion, cocaine and nomifensine on
dopamine and acetylcholine release from the rabbit striatum. Soc. for Neuroscience, 1983.
70. James, M.K. and Cubeddu, L.X.: Frequency dependent effects of muscarinic receptor stimulation on striatal
dopamine and acetylcholine release. Soc. for Neuroscience, 1983.
71. Niedzwiecki, D.M., Cubeddu, L.X. and Mailman, R.B.: Thioridazine metabolites are more potent than thioridazine
in regulating neurotransmitter release from striatal slices. Soc. for Neuroscience, 1983.
72. Cubeddu, L.X., Simpson, R.J., Rogers, J.F., Gross, K.M. and Halperin, A.K.: Verapamil (V) and propranolol (P) in
essential hypertension (EHT). Amer. Soc. for Clinical Pharmacology and Therapeutics, March 1984.
73. Cubeddu, L.X., Carr, M. and Fuenmayor, N.: Comparative beta blocking potencies of propranolol and labetalol in
normal volunteers. Labetalol Update: A Clinical Forum. Isle of Palms, South Carolina, Sept. 1984.
74. Cubeddu, L.X., Dubocovich, M.L., Weiner, N., Tepper, J. and Bannon, M.J.: Symposium. Autoreceptors and
Modulation of Neurotransmitter Release. Soc. for Neuroscience, 1984.
75. Cubeddu, L.X., Halperin, A.K., Webb, K.G. and Rogers, J.F.: Comparative effects of verapamil and propranolol in
essential hypertension. Amer. Soc. for Clinical Pharmacology and Therapeutics, March 1985.
76. Carr, M.E., Fuenmayor, N. and Cubeddu, L.X.: Comparative beta blocking potencies of oral propranolol and
labetalol in normal volunteers. Amer. Federation for Clinical Research, May 1985.
77. Cubeddu, L.X.: Calcium channel blockers as monotherapy in hypertension. Symposium on the Current Status of
Calcium Channel Blockers in Hypertension. Southampton, Bermuda, July 1985.
78. James, M.K. and Cubeddu, L.X.: Pharmacological characterization of muscarinic receptors regulating 3H-ACh
release from rabbit striatum. Amer. Soc. for Pharmacology and Experimental Therapeutics, August 1985.
79. Cubeddu, L.X.: Antihypertensive efficacy of verapamil in black and white patients with essential hypertension.
Symposium on A New Era in Hypertension Management: Calcium Antagonists. Puerto Vallarta, Mexico, Sept. 1985.
80. Cubeddu, L.X.: Comparative effects of verapamil and propranolol in hypertension. Symposium on Hypertension -
The Next Decade: Verapamil in Focus. Berlin, West Germany, Oct. 1985.
81. Cubeddu, L.X.: Acute and chronic studies on the antihypertensive effect of verapamil and other calcium channel
blockers. Verapamil Conference. Phoenix, Arizona, Nov. 1985.
23